Delivery Order SPE2DB25D3007-SPE2DB25FWSHR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count) valued at $1,555.93 under a firm fixed price contract. The award was made on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,222.21 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, effective July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order represents a straightforward pharmaceutical procurement with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,626.48 to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- This delivery order, awarded July 23, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 100 tablets of Clobazam 10 mg at a ceiling value of $6,303.15. The contract is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets in a quantity of 100 units, valued at $3,111.86. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The contract was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,282,982 tablets of the medication Clobazam 10 mg. The $11,790.30 order has a completion date of January 10, 2024 and was awarded on January 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product to the designated location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency Troop Support Medical awarded a $253,050 delivery order to Amerisourcebergen Drug Corporation for 100-count packages of 10 mg Clobazam tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 18-21, 2023. No additional details were provided on the original solicitation or whether this delivery order falls under an existing indefinite-delivery/indefinite-quantity contract...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,618,636 units of Clobazam 10 mg tablets in 100-count packages. The $3,111.86 contract has a completion date of February 12, 2024. AmerisourceBergen Drug Corp, which serves as a prime contractor for the DLA Troop Support Medical program, has previously been awarded indefinite delivery contracts (IDCs) by...
- The Defense Logistics Agency awarded a $5,030.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- SPE2DB25D3007Indefinite Delivery Contract
- SPE2DB25D3007-SPE2DB25FWSHRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, a medication used to treat seizure disorders. This non-set-aside, competitively awarded contract is valued at $3,510.52 and carries a firm fixed price structure with a completion date of July 22, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a critical vendor for the Defense Health Agency and other federal healthcare systems, AmerisourceBergen has demonstrated capability to fulfill federal pharmaceutical requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/21/25 |